wire - news in brief

« BACK

Health



Results 1 - 50 of 188.
1 2 3 4 Next »


Pharmacology - Health - 11.04.2025
A public-private partnership to assess a novel drug candidate for Parkinson’s disease

Health - Life Sciences - 27.03.2025
VUB Professor Rose Njemini: ’Exercise is the most powerful medicine for healthy aging’

Campus - Health - 17.03.2025
Future students and their families discover the Uni at Open Day 2025 

Health - Psychology - 14.03.2025
How gender inequalities influence medical diagnosis and treatment
Despite progress in women's rights, gender inequalities persist in many areas, including healthcare.

Health - Campus - 27.02.2025
GUARD strengthens rare disease research
GUARD strengthens rare disease research

Health - Research Management - 12.02.2025
Supporting research through targeted fundraising

Health - 19.12.2024
Today’s Lonely Youth Are Tomorrow’s Lonely Elderly

Health - Pharmacology - 19.12.2024
Tailored Cancer Treatment: VUB Research Predicts Which Patients Benefit from Immunotherapy
A team of scientists led by researchers from the Vrije Universiteit Brussel (VUB) and the Flemish Institute for Biotechnology (VIB) has developed a new technology to precisely predict and monitor cancer patients' responses to immunotherapy. Immunotherapy is a type of cancer treatment that stimulates a patient's immune system to attack tumors.

Health - Pharmacology - 09.12.2024
Therapeutic potential of a novel mixture of mRNA in nanoparticles overcomes tumor progression
Therapeutic potential of a novel mixture of mRNA in nanoparticles overcomes tumor progression
Brussels, December 9, 2024 - Therapeutic mRNAs offer great potential as a versatile and precise tool against cancer and various other diseases.

Pedagogy - Health - 20.11.2024
ENLIGHT calls: Ghent University in 12 of 17 winning projects
ENLIGHT calls: Ghent University in 12 of 17 winning projects

Health - Pharmacology - 10.10.2024
New KU Leuven spin-off fosters therapeutic treatment in everyday life
With the help of a science-based smartphone app, psychotherapists and psychologists can now enhance their patients' treatment with interventions and assessments in everyday life.

Health - Innovation - 02.10.2024
KU Leuven spin-off enables more targeted gene therapy
Gene therapy uses safe viruses to fix or replace faulty genes, making it possible to correct the genetic cause of a disease - something that was not possible before.

Life Sciences - Health - 05.09.2024
5 Ghent researchers win an ERC Starting Grant
5 Ghent researchers win an ERC Starting Grant

Health - Veterinary - 12.08.2024
HEARTS - Revolutionary system for Equine Cardiac Emergency Care
HEARTS - Revolutionary system for Equine Cardiac Emergency Care

Life Sciences - Health - 11.07.2024
Ghent University spin-off Trince wins Nature Spinoff Prize
Ghent University spin-off Trince wins Nature Spinoff Prize

Health - 10.07.2024
Discover the University’s 2023 Highlights!

Politics - Health - 09.07.2024
The rise of the far-right in Europe: understanding the political shift through research
Although the left-wing coalition of the New Popular Front won the early legislative elections in France this Sunday, the far-right, through the National Rally, nonetheless achieved the most significant breakthrough in its history.

Health - Campus - 24.06.2024
Koen Putman Appointed as New Dean of VUB Faculty of Medicine and Pharmacy
Koen Putman Appointed as New Dean of VUB Faculty of Medicine and Pharmacy

Health - Innovation - 24.06.2024
A gut-on-chip device for personalised health solutions

Health - Life Sciences - 07.06.2024
First Marie Speyer Grants awarded to outstanding women researchers

Health - Pharmacology - 04.06.2024
A Belgian-led consortium ’making antibiotics great again’ with phage* therapy
The Belgian-led consortium consisting of groups from The Queen Astrid Military Hospital (QAMH), KU Leuven and the public health institute Sciensano recently made the cover of Nature Microbiology.

Health - Pharmacology - 02.05.2024
KU Leuven Secures $2.8 Million Grant to Investigate Origins of Crohn’s Disease Fibrosis
Crohn's disease, affecting approximately 2 million people around the world, manifests with intestinal inflammation and abdominal pain.

Health - Life Sciences - 26.04.2024
LCSB on Tour: Research at your doorstep!

Health - Life Sciences - 09.04.2024
How do food and lifestyle affect brain health? 
How do food and lifestyle affect brain health? 
The Vrije Universiteit Brussel research group NEUR , the Neurology Department of the UZ Brussel and Professor Sebastiaan Engelborghs are taking part in an international research project led by Wageningen University & Research in the Netherlands.

Microtechnics - Health - 13.03.2024
Team in full preparation for CYBATHLON in Zurich
Team in full preparation for CYBATHLON in Zurich
A team of engineers and physiotherapists from the Robotics and Multibody Mechanics laboratory (R&MM) and the research group Human Physiology and Sports Physiotherapy (MFYS) is busy preparing for the 2024 CYBATHLON.

Health - 11.03.2024
VUB organises symposium on sleep and sleep medicine

Life Sciences - Health - 01.03.2024
Multiple genders, one brain?

Health - Innovation - 28.02.2024
Researchers design medicine of the future
The success rates in securing European funding demonstrate that the Vrije Universiteit Brussel is committed to research and innovation.

Innovation - Health - 28.02.2024
Ghent University & FTI bring a technological spectacle to the Winter Circus
Ghent University & FTI bring a technological spectacle to the Winter Circus

Chemistry - Health - 28.02.2024
VUB hosts lecture by Nobel Prize winner Ben Feringa

Environment - Health - 14.02.2024
Climate change contributes to rise of West Nile virus in Europe
Climate change contributes to rise of West Nile virus in Europe
A team of researchers from the Spatial Epidemiology Lab ( SpELL ) of the Université libre de Bruxelles (ULB) and the bclimate group of the Vrije Universiteit Brussel (VUB) demonstrate in a new publication the contribution of climate change to the geographical expansion of West Nile virus in Europe.

Life Sciences - Health - 09.02.2024
VUB professor discovers genetic cause of low birth weight among children conceived after fertility treatment
VUB professor discovers genetic cause of low birth weight among children conceived after fertility treatment
VUB professor Claudia Spits, of the Reproduction and Genetics research group, has identified a genetic cause for the increased risk of low birth weight in babies born following assisted reproductive technologies such as IVF.

Health - Pharmacology - 01.02.2024
VUB to lead international consortium on palliative care for chronic lung disease

Health - Pharmacology - 17.01.2024
GLIOMATCH: Pioneering hope for malignant glioma, a deadly brain cancer
The World Health Organization reveals a sombre reality: cancer ranks as the world's second-leading cause of death.

Health - Campus - 21.12.2023
2024, a new milestone year at the University

Health - Pharmacology - 13.12.2023
An AstraZeneca-FNRS-FWO Foundation award for Charlotte Beaudart

Health - Campus - 12.12.2023
Flemish minister Ben Weyts visits VUB University Dental Centre

Health - 08.12.2023
KU Leuven formally opens new research centre for innovative gene therapy
KU Leuven formally opens new research centre for innovative gene therapy
Flemish Minister for Economy, Science and Innovation Jo Brouns has inaugurated a new research facility for innovative gene therapy at KU Leuven.

Health - Pharmacology - 04.12.2023
Mathieu Vinken, a professor in the In Vitro Toxicology and Dermato-cosmetology (IVTD) lab at the Vrije Universiteit Brussel, and doctoral candidate Raf Van Campenhout have developed a technique based on nanobody technology to prevent liver inflammation. Nanobodies, or single-domain antibodies, are fragments of antibodies that can selectively bind to a specific antigen. Because they are simple to produce and react in very specific ways, they are often used in various biotechnological, therapeutic and diagnostic applications.  
Mathieu Vinken, a professor in the In Vitro Toxicology and Dermato-cosmetology (IVTD) lab at the Vrije Universiteit Brussel, and doctoral candidate Raf Van Campenhout have developed a technique based on nanobody technology to prevent liver inflammation. Nanobodies, or single-domain antibodies, are fragments of antibodies that can selectively bind to a specific antigen. Because they are simple to produce and react in very specific ways, they are often used in various biotechnological, therapeutic and diagnostic applications.  

Health - 17.11.2023
3D model of the testis 
3D model of the testis 

Life Sciences - Health - 17.11.2023
Three Uni.lu professors on the Highly Cited Researchers 2023 list

Health - Campus - 08.11.2023
Rural medicine: the UNamur inaugurates a university observatory

Research Management - Health - 26.10.2023
KU Leuven and University of Melbourne extend collaboration with extra investment of ¤10 million and 20 new research projects

Pharmacology - Health - 24.10.2023
KU Leuven research into the treatment of endometriosis receives substantial Danish support
KU Leuven and the Danish BioInnovation Institute (BII) will jointly look for new therapeutic drugs for the gynecological disorder endometriosis over the next three years.

Health - Pharmacology - 19.10.2023
The Centre for Drug Design and Discovery raises 70.5 Million Euros for its fourth fund

Health - 10.10.2023
AI and robotics as sources of solutions in the medical sector

Health - 03.10.2023
VUB launches chair with Alex Agnew
VUB launches chair with Alex Agnew

Health - Research Management - 28.07.2023
ERC Proof of Concept Grant for two Ghent researchers
ERC Proof of Concept Grant for two Ghent researchers

Pharmacology - Health - 14.07.2023
VUB neurologist argues for affordability of new Alzheimer’s drug

Health - Life Sciences - 16.06.2023
VUB professor Antonella Fioravanti knighted in order 'Stella d'Italia'
VUB professor Antonella Fioravanti knighted in order ’Stella d’Italia’
1 2 3 4 Next »